• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Comparation Between Laparoscopy Assisted Gastrectomy D2 Lymhp Node Dissection and Open Procedure for Gastric Cancer in Colombia

Comparation Between Laparoscopy Assisted Gastrectomy D2 Lymhp Node Dissection and Open Procedure for Gastric Cancer in Colombia

INTRODUCTION: To evaluate the morbidity and mortality of laparoscopy assisted gastrectomy and D2 lymph node disecction and compare with the open surgery in a period of 3 years in patients with advanced gastric cancer in a one institucion in colombia.
The gastric cancer is the second most common cancer worldwide in our country is the first cause of death related for cancer.
We dont have screening programs and the advanced state is theprincipal diagnosis for our patients. surgical resection is the only treatment that may offer a cure for this patients.
Gastrectomy and D2 with curative intent have been recommend for the treatment for gastric cancer . Laparoscopy surgery is a powerfull option in oncology.
We want to demostrate the many advantages of the laparoscopic surgery over the conventional surgery and the excellent oncology results for the treatment and survival .
METHODS AND PROCEDURES: sixty five patients with gastric cancer in a period of january 2006 and june 2009 with no metastatic cancer were enrolled in the present study. Design retrospective analysis. The patients were operated for the same oncology surgeon in the Las Americas Oncology Institute. We reviewed the surgical outcomes, clinicopathologic characteristic, operative time and postoperatives morbidities and mortalities in were compares after dividing in 2 groups 33 open and 32 laparoscopy.
RESULTS: Open an laparoscopic gastrectomy with D2 lymph node were perfomed in 33 and 32 patiens, respectively. Total and subtotal were in 7 and 28 procedures. 66% was men and 34% women. The first symptom was heartburn following for gastrointestinal bleeding.
The endoscopy shown 70% of ulcer lesions, in antrum and 77% Borman III.
The CTA scan were negative for metastatic disease.
20% were family antecedents of gastric cancer.
94% had more the 16 lymph nodes and the nodal index was > 20 in the 96%.
The recurrence were more in the open procedure 12% vs 3%, the complications were 24% in open surgery ( 4 leaks, 2 wouds infection, 1 neumothorax) and 3% in laparoscopic gastrectomy ( 2 leaks, 1 wound dehiscense). The mortality was equall in the groups 1 patient each one.
The operative time was 140 minutes.
CONCLUSION: Laparoscopy assisted gastrectomy with D2 lymph node is acceptable oncologically in advanced gastric cancer in our institution, with low rates of recurrence, low morbility and mortality, and well accepted for the patients.
The node index were acceptable in the 96% of the patients.


Session: Poster

Program Number: P331

View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search